Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Trends in primary endocrine therapy utilization among patients with early-stage ER+/HER2− breast cancer who do not undergo surgery: A National Cancer Database analysis.

44 Background: Primary endocrine therapy (pET) is a mainstay of cancer treatment for patients with estrogen receptor-positive (ER+) breast cancer who are unfit for surgery. As the multidisciplinary breast oncology teams continue to personalize cancer therapies for patients, we have noticed pET being expanded to...

Christopher M. Fiorina, M. Luqman, M. Cowher et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.